Almost nobody searches for a Wegovy alternative because they want a different drug. They search because something got in the way: a list price above $1,300 a month, a denied claim, side effects they could not ride out, or a scale that stopped moving. The closest alternative is compounded semaglutide, which contains the same active ingredient as Wegovy at a fraction of the cost. The strongest is compounded tirzepatide, which beat semaglutide directly in a head-to-head trial. Work out which blocker is yours, then match it to the option below.

Quick Answer: What Is the Best Alternative to Wegovy?

There are two answers, and which one is right depends on what stopped you.

If cost or coverage is the problem, compounded semaglutide is the closest match. It contains the same active ingredient as Wegovy, follows the same weekly dose ladder, and starts at $89 a month at MaxLife on a 3-month starter package, then $155 a month, with no insurance needed.

If you want more weight loss, compounded tirzepatide is the stronger option. In a direct head-to-head trial, tirzepatide produced 20.2 percent average body weight loss versus 13.7 percent for semaglutide over 72 weeks. It starts at $120 a month on a 3-month starter package, then $195 a month.

One honest caveat applies to both: compounded medications aren't FDA-approved and aren't covered by insurance. If you want an FDA-approved route, Zepbound (brand-name tirzepatide) and the Wegovy pill (oral semaglutide) are the main options, at higher prices. Older non-GLP-1 weight loss drugs exist too, but they typically produce noticeably less weight loss than any of these.

Why Do You Need a Wegovy Alternative?

Four things drive people to look, and each points in a different direction.

Cost. This is by far the most common reason. Wegovy's list price is $1,349.02 per package, roughly a month's supply. Novo Nordisk now sells it direct for cash at $349 a month, which helps, but it is still more than double what compounded semaglutide costs at MaxLife. (See our full breakdown of semaglutide cost.)

Insurance denial. Most plans treat weight-loss medication as an optional benefit and exclude it outright. A denial is usually a plan design decision, not a judgment about you. (More on this in our guide to weight loss drugs covered by insurance.)

Side effects. Nausea, vomiting and diarrhea are the ones that end treatment. The issue is almost always severity, not the molecule itself, and severity is usually a dose problem.

A plateau. You reached 2.4 mg, stayed there, and the loss stopped. That calls for a different mechanism, not a cheaper one.

Cost and coverage lead to the same molecule at a lower price. A plateau leads to a different molecule. Side effects lead to a dosing conversation first. Get this wrong and you switch to something that does not fix your actual problem.

Wegovy Alternatives at a Glance

Option	Active ingredient	Weight loss vs Wegovy	Form and frequency	FDA-approved	Insurance needed	Typical monthly cost
Wegovy (reference)	Semaglutide	About 15% average body weight loss in trials	Prefilled pen, once weekly	Yes	Not required, but list price is high without it	$1,349 list; $349 direct cash price
Compounded semaglutide	Semaglutide (identical to Wegovy)	Same active ingredient, same dose ladder	Vial and syringe, once weekly	No	No	From $89 at MaxLife (3-month starter package), then $155
Compounded tirzepatide	Tirzepatide (GLP-1 and GIP)	Greater: 20.2% vs 13.7% head-to-head	Vial and syringe, once weekly	No	No	From $120 at MaxLife (3-month starter package), then $195
Zepbound	Tirzepatide (GLP-1 and GIP)	Greater: 20.2% vs 13.7% head-to-head	Vial or prefilled pen, once weekly	Yes	Not required	About $1,086 list; $299 to $449 self-pay via LillyDirect
Wegovy pill	Semaglutide (oral)	Close: about 14% average loss in trials	Tablet, once daily	Yes	Not required	From $149 self-pay via NovoCare
Other prescription options	Various non-GLP-1 agents	Less: typically single-digit percentages	Mostly daily oral	Yes, varies by drug	Varies; several are inexpensive generics	Varies widely

The pattern is easy to miss in a table this wide, so here it is plainly. The two compounded alternatives to Wegovy are not weaker drugs. One is the same molecule at a much lower price. The other is a stronger molecule at a moderately higher price. Zepbound and the Wegovy pill are the FDA-approved versions of those same two molecules, at a higher monthly cost. The older non-GLP-1 options trade effectiveness for a lower price tag, and for most people that is the wrong trade.

1. Compounded Semaglutide: The Same Active Ingredient

Compounded semaglutide contains semaglutide, the identical active ingredient in Wegovy. A licensed compounding pharmacy prepares it based on a prescription from your licensed provider. It follows the same weight-management titration, starting at 0.25 mg and stepping up every four weeks, and it is injected once weekly. It works the same way: reduced appetite, slower gastric emptying, and the quieting of food noise most people notice before the scale moves.

The differences are real. It arrives as a vial you draw with a syringe rather than a prefilled pen. It is not a generic, because no generic Wegovy exists. And it is not FDA-approved, meaning it has not been reviewed for safety or efficacy the way approved drugs are, and it is not covered by insurance. (For how the brands and compounded versions relate, see semaglutide vs Ozempic.)

The efficacy statement has to be honest as well. In the STEP 1 trial, semaglutide 2.4 mg once weekly produced a mean 14.9 percent reduction in body weight over 68 weeks, compared with 2.4 percent on placebo. That trial studied the approved product. Results for a compounded version are inferred from the active ingredient and dose, not demonstrated in a trial.

For someone blocked purely by price, this is still the closest thing to Wegovy.

2. Compounded Tirzepatide: The Stronger Option

Compounded tirzepatide is the answer for the reader who did everything right and stalled anyway. The mechanical difference is straightforward: tirzepatide activates two hormone receptors, GLP-1 and GIP, while semaglutide activates one. That dual action is the leading explanation for the gap in results.

The gap has been measured directly. In SURMOUNT-5, a 72-week head-to-head trial of 751 adults with obesity and without diabetes, tirzepatide produced a 20.2 percent average reduction in body weight versus 13.7 percent for semaglutide. That is not a cross-trial comparison or a marketing estimate. It is the same patients, the same study, the same 72 weeks.

It is also a once-weekly injection, so nothing about your routine changes. Same day of the week, same injection, same fridge.

The trade-offs are worth knowing. Gastrointestinal side effects tend to be more pronounced at higher doses, and titration matters more, not less. It costs more than compounded semaglutide, starting at $120 a month rather than $89 on a 3-month starter package, then $195 rather than $155. And it is compounded, so the same caveats apply: not FDA-approved, not a generic, not covered by insurance.

If FDA approval matters more to you than price, Zepbound is the brand-name version of tirzepatide, approved for chronic weight management. Eli Lilly sells it self-pay through LillyDirect for roughly $299 to $449 a month depending on dose, and some insurance plans cover it. (For the full breakdown, see our tirzepatide cost guide.)

If you want an alternative to Wegovy because Wegovy wasn't enough, this is the option with actual head-to-head evidence behind it.

3. Other Prescription Weight Loss Options

Other prescription weight loss medications exist, and a prescriber may consider one, particularly for someone who cannot take a GLP-1 at all. These include older appetite suppressants and combination oral agents. There is also the Wegovy pill, an FDA-approved once-daily oral form of semaglutide that produces results much closer to the injection than other oral options do, with self-pay pricing from $149 a month through NovoCare.

Two things are worth clarifying. First, non-GLP-1 options generally produce single-digit percentage weight loss, compared with the 15 to 20 percent range seen with GLP-1 and dual-agonist injections. That is a meaningful difference in outcome, not a rounding error. Second, several of them carry contraindications that rule out a real share of people, including cardiovascular history, seizure history, uncontrolled hypertension, pregnancy, and interactions with common psychiatric medications. (For one example compared side by side, see Contrave vs semaglutide.)

MaxLife offers injections only and does not prescribe these. If a GLP-1 is off the table for you medically, that is a conversation with your own prescriber, who can weigh your history against what each option requires. It is a legitimate route; it is just a different one, and it belongs with a clinician who knows your chart.

4. Switching Because of Side Effects

If your blocker is tolerance rather than cost, start with the distinction that most people miss. Severe side effects usually mean the titration moved too fast or the dose is too high for you right now. They rarely mean the medication is wrong for you.

So the first move is not a new drug. It is a conversation with your provider about holding your current dose for another month, or stepping back one level and climbing more slowly. Nausea, constipation, fatigue and reflux commonly ease over several weeks at a stable dose. Slowing down costs you time, not results.

If that genuinely does not work, there is a reasonable next step. Semaglutide is generally the gentler of the two molecules, so someone struggling on tirzepatide may do better on semaglutide. The reverse move, from semaglutide to tirzepatide because of side effects, is less likely to help.

Some symptoms are not a titration problem at all. Severe or persistent abdominal pain, especially pain radiating to the back, vomiting you cannot keep down, or signs of dehydration mean stop and call a provider, not switch products on your own.

5. Fixing the Cost Problem Without Switching Drugs

Before you change anything, spend an afternoon reviewing your current coverage.

Check whether your plan covers semaglutide under a different indication. Some exclude weight management but cover the same molecule for cardiovascular risk reduction, depending on your documented history.

Pursue prior authorization, and if you are denied, appeal quickly. Internal appeal windows are short, often 180 days and sometimes less, and a denial letter that sits on a counter for two months can close the door on its own.

Use a manufacturer savings card if your commercial insurance already covers the drug. Novo Nordisk's Wegovy savings offer can bring covered patients to as little as $25 a month, capped monthly. It does nothing for uninsured or excluded patients.

Use an HSA or FSA. Prescriptions that insurance refuses to cover still count as eligible medical expenses under IRS rules, so you are effectively paying with pre-tax dollars.

The honest close: for many people, none of this works. Weight-loss coverage remains uncommon, and appeals rarely overturn a plan exclusion. That is why the compounded route makes treatment affordable for many people. MaxLife program expenses may be eligible for FSA or HSA reimbursement, depending on your plan's rules.

How to Choose Your Wegovy Alternative for Weight Loss

Match the blocker to the answer. It really is this direct.

Priced out, or denied coverage. Compounded semaglutide. Same molecule as Wegovy, same weekly ladder, starting at $89 a month on a 3-month starter package, then $155 a month, no insurance involved.

Plateaued, or you want more weight loss. Compounded tirzepatide. The head-to-head winner at 20.2 percent versus 13.7 percent, starting at $120 a month on a 3-month starter package, then $195 a month.

Rough side effects. Discuss your dose before you discuss switching. Most tolerance problems are titration problems, and changing drugs without changing pace tends to reproduce the same week.

You cannot take a GLP-1 medically. That is a prescriber conversation about a different class of medication, not a purchase decision.

Under 18. This is not the right route. MaxLife serves adults for weight management only, and a pediatric prescriber should lead adolescent treatment.

Choosing a Wegovy alternative for weight loss narrows the field, but it does not settle it. Eligibility and the final choice belong to a licensed provider who has reviewed your history, your medications and your goals.

What to Check Before You Switch

The compounded market has serious operators and thin ones, and the homepage price will not tell you which is which. Before you hand over a card, confirm the following.

Is a licensed provider in your state reviewing your eligibility? A questionnaire nobody reads is not a medical review.
Is the compounding pharmacy named, licensed and identifiable? You should be able to look it up.
Are you getting base semaglutide or a salt form? Salt forms such as semaglutide sodium and semaglutide acetate are not the same substance as the semaglutide in approved products.
Do you get written dosing instructions for your specific vial? Concentrations differ between pharmacies, and units on a syringe are not milligrams.
Does the price include medication and supplies? Needles, syringes and alcohol wipes should not appear later as an add-on.
Are there separate membership or lab fees? Ask for the all-in number.
Does the price rise after month one? Intro pricing that jumps at your first dose increase is common.
How many months must you pay upfront? A low headline price often assumes a six-month prepayment.

A low advertised price is often not the real number. Ask what you will actually pay in month four.

Start Your Wegovy Alternative With Medical Guidance

Switching is a clinical decision, not a shopping decision. The right alternative depends entirely on why Wegovy didn't work for you, and that question deserves a provider's answer rather than a checkout page's.

MaxLife offers both options in one place: compounded semaglutide starting at $89 a month and compounded tirzepatide starting at $120 a month on a 3-month starter package, then $155 and $195 a month after that. Medication, supplies, licensed provider review, ongoing support and free overnight shipping are included. No insurance is required, and program expenses may be eligible for FSA or HSA reimbursement, depending on your plan.

The eligibility check takes a few minutes. See whether a GLP-1 is right for you.

Conclusion

The best Wegovy alternative depends on why you need one. If cost or coverage blocked you, compounded semaglutide is the same active ingredient, starting at $89 a month on a 3-month starter package, then $155 a month. If you wanted more weight loss, compounded tirzepatide won the head-to-head trial at 20.2 percent versus 13.7 percent and starts at $120 a month on a 3-month starter package, then $195 a month. Both are once-weekly injections, both are compounded rather than FDA-approved, and neither is covered by insurance. If side effects were the problem, the answer is usually the dose rather than the drug. Eligibility, in every case, belongs to a licensed provider.

Wegovy Alternative FAQs

What is the closest alternative to Wegovy?

Compounded semaglutide. It contains semaglutide, the same active ingredient as Wegovy, follows the same weight-management dose ladder, and is injected once weekly. The differences are the format, a vial and syringe rather than a prefilled pen, and the regulatory status: it is not FDA-approved and not covered by insurance.

Is compounded semaglutide the same as Wegovy?

Same active ingredient, not the same product. Wegovy is an FDA-approved, brand-manufactured medication reviewed for safety and efficacy. Compounded semaglutide is prepared by a licensed compounding pharmacy against an individual prescription and is not FDA-approved. It is also not a generic because no generic version of Wegovy exists.

Is there a cheaper version of Wegovy?

There is no generic, but there are cheaper routes to the same molecule. Novo Nordisk sells Wegovy direct for cash at $349 a month, well below the $1,349 list price. Compounded semaglutide starts at $89 a month at MaxLife on a 3-month starter package, then $155 a month, with no insurance needed. The trade-off for the lower price is that compounded medication is not FDA-approved.

Can I switch from Wegovy to compounded semaglutide, and what dose do I start on?

Yes, and this is a common switch. Because the active ingredient is the same, providers will often continue you near your current dose rather than restarting the ladder from 0.25 mg, but that decision is theirs to make based on how long you have been treated and how well you tolerated it. Do not assume your dose carries over. Vial concentrations vary between pharmacies, so follow the written instructions issued for your specific vial rather than converting from your old pen.

What is a stronger alternative to Wegovy?

Tirzepatide. It acts on two receptors, GLP-1 and GIP, and in the 72-week SURMOUNT-5 head-to-head trial, it produced 20.2 percent average body weight loss against 13.7 percent for semaglutide. Compounded tirzepatide starts at $120 a month at MaxLife on a 3-month starter package, then $195 a month, and Zepbound is the FDA-approved brand of the same molecule. Both are once weekly, and side effects tend to be more noticeable at the higher doses.

Is there an over-the-counter alternative to Wegovy?

No. Semaglutide and tirzepatide are prescription-only, and no over-the-counter supplement has been shown to produce results close to these. Products marketed online as oral semaglutide drops, patches or "GLP-1 boosters" without a prescription are not legitimate versions of these medications. Anything that genuinely replaces Wegovy requires a prescription from a licensed provider.

Wegovy Alternative: 5 Options That Actually Work